[144] iRhythm Technologies, Inc SEC Filing

Rhea-AI Filing Summary

The filing is a Form 144 for iRhythm Technologies (IRTC) reporting a proposed sale of 5,312 common shares with an aggregate market value of $839,380.46. The shares are listed for sale on NASDAQ with an approximate sale date of 08/11/2025 and the issuer's total shares outstanding are reported as 32,127,763.

The filer states the shares were acquired on 08/11/2025 by stock option exercise from the issuer, with payment in cash, and the proposed sale will be executed through Morgan Stanley Smith Barney LLC. The form indicates nothing to report for securities sold by the filer in the past three months and includes the filer's representation that they do not know of undisclosed material adverse information about the issuer.

Insights

Securities Analyst

TL;DR: Routine Form 144 disclosing exercise and proposed sale of 5,312 shares valued at $839,380.46.

The filing documents a proposed sale through Morgan Stanley Smith Barney LLC of 5,312 common shares of iRhythm (IRTC) with an aggregate market value of $839,380.46, scheduled approximately for 08/11/2025. The shares were acquired the same day by stock option exercise from the issuer and paid for in cash. The filer reports no securities sold in the past three months. From a securities disclosure perspective, this is a straightforward compliance filing under Rule 144 that records an intended sale rather than an executed trade.

Corporate Governance Expert

TL;DR: Form 144 documents compliance with Rule 144 for a proposed insider sale and includes the filer's standard representation about non-public material information.

The notice identifies the transaction as a proposed sale of common stock acquired by a stock option exercise and routed through a named broker, Morgan Stanley Smith Barney LLC. The filing also contains the formal attestation that the person for whose account the securities are to be sold does not know of any undisclosed material adverse information about the issuer. This filing therefore records the procedural steps required before an insider sale under Rule 144.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5312	839380.46	32127763	08/11/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/11/2025	Stock Option Exercise	ISSUER			5312	08/11/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the iRhythm (IRTC) Form 144 report?

The form reports a proposed sale of 5,312 common shares of iRhythm with an aggregate market value of $839,380.46, to be sold on 08/11/2025 on NASDAQ.

How were the shares acquired that are being offered for sale on the Form 144?

The shares were acquired on 08/11/2025 by stock option exercise from the issuer, and payment was made in cash.

Who is the broker named on the Form 144 for the IRTC proposed sale?

The broker listed is Morgan Stanley Smith Barney LLC located at 1 New York Plaza, 8th Floor, New York, NY.

Does the filing report any securities sold by the filer in the past three months?

The filing states Nothing to Report for securities sold by the person in the past three months.

What attestation does the filer make on the Form 144?

The filer represents by signing the notice that they do not know of any material adverse information regarding the issuer that has not been publicly disclosed.